Sublingual immunotherapy for pediatric patients with mite allergies
| Autor: | Teruyuki Kajiume |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Drug-Related Side Effects and Adverse Reactions Pruritus Pyroglyphidae Administration Sublingual Observational Study Dust General Medicine Immunoglobulin E Rhinitis Allergic sublingual immunotherapy Treatment Outcome allergy and immunology Desensitization Immunologic Child Preschool Hypersensitivity Animals Humans Female Antigens Dermatophagoides Child Research Article house dust mites |
| Zdroj: | Medicine |
| ISSN: | 1536-5964 |
| Popis: | Sublingual immunotherapy (SLIT) has been increasingly used instead of subcutaneous immunotherapy. SLIT was initially approved for use among adults; however, it has become more widely accepted for children. Few studies have evaluated the effectiveness of SLIT in the treatment of dust mite allergies among children, including adverse effects. This study aimed to investigate the effectiveness of SLIT in children with dust mite allergies, as well as its adverse effects, at a pediatric general outpatient clinic. I analyzed the data of 181 patients aged 4 to 12 years who tested positive for mite antigen-specific immunoglobulin E, exhibited nasal and/or eye symptoms, and received Miticure. Symptoms were evaluated using the Japanese rhino-conjunctivitis quality of life (QOL) questionnaire no. 1. Wilcoxon tests were used to compare the pretreatment and post-treatment symptom scores. Adverse events were tallied, and Kaplan–Meier curves and Wilcoxon tests were used to assess the proportion of dropouts. The mean QOL score at the baseline was 2.17 (standard deviation [SD] 1.45). After 1 week, the mean symptom QOL score was 1.63 (SD 1.32); the lowest mean score was found in week 41 (0.48, SD 0.63). A significant decline in the occurrence of all symptoms, including sneezing, nasal discharge, nasal congestion, itchy eyes, and teary eyes, was observed. Adverse effects were observed in 76 (42.0%) patients; the most common adverse effect was itchy mouth. SLIT improves symptoms with minimal adverse effects in pediatric patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|